Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044199 · ClinicalTrials.gov registry record · NA
Study of Intradermal Administration of PCEC Rabies Vaccine
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT01044199 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 130 participants.
The verdict
NCT01044199, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.
Interventions
- BIOLOGICAL PCEC rabies vaccine given intradermally
- BIOLOGICAL PCEC rabies vaccine administered intramuscularly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044199
The ClinicalTrials.gov registry entry for NCT01044199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PCEC rabies vaccine given intradermally is the first listed.
NCT01044199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044199 about?
NCT01044199 is a clinical study titled "Study of Intradermal Administration of PCEC Rabies Vaccine". The purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.
What is the current status of trial NCT01044199?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2009-02. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01044199?
The interventions under investigation include: PCEC rabies vaccine given intradermally (BIOLOGICAL), PCEC rabies vaccine administered intramuscularly (BIOLOGICAL).
Who is sponsoring clinical trial NCT01044199?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.